Comorbidity of insomnia with medical and psychiatric disorders

Economics of Neuroscience

Volumn 3, Issue 9, 2001, Pages 48-57

  Martinez Gonzalez, D ^a   Obermeyer, W H ^a   Benca, R M ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMOXAPINE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE; BUSPIRONE; CARBAMAZEPINE; ESTAZOLAM; FLURAZEPAM; GABAPENTIN; LAMOTRIGINE; LITHIUM; MAPROTILINE; MELATONIN; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NEUROLEPTIC AGENT; QUAZEPAM; SEROTONIN UPTAKE INHIBITOR; TEMAZEPAM; TIAGABINE; TRAZODONE; TRIAZOLAM; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE; ZALEPLON; ZOLPIDEM;

AFFECTIVE NEUROSIS; AGING; ALCOHOLISM; ANXIETY NEUROSIS; ARTICLE; BEHAVIOR THERAPY; COMORBIDITY; DEMENTIA; DEPRESSION; DEVELOPMENTAL BIOLOGY; DRUG HALF LIFE; EATING DISORDER; HEALTH CARE COST; HEART DISEASE; HUMAN; INCIDENCE; INSOMNIA; LUNG DISEASE; MENTAL DISEASE; MORBIDITY; MUSCULOSKELETAL DISEASE; PREVALENCE; PROSTATE DISEASE; QUALITY OF LIFE; RELAXATION TRAINING; RISK FACTOR; SCHIZOPHRENIA;

EID: 0034800421     PISSN: 15270815     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (108)

1. Epidemiologic study of sleep disturbance and psychiatric disorders: An opportunity for prevention?
2. Insomnia and its treatment. Prevalence and correlates
3. Prevalence of sleep disorders in the Los Angeles metropolitan area
4. Characteristics of insomnia in the United States: Results of the 1991 National Sleep Foundation Survey. I
5. Prevalence, burden, and treatment of insomnia in primary care
6. Daytime consequences and correlates of insomia in the United States: Results of the 1991 National Sleep Foundation Survey. II
7. The direct economic costs of insomnia in the United States for 1995
8. The direct costs of insomnia in France
9. The morbidity of insomnia uncomplicated by psychiatric disorders
10. Evaluation of severe insomnia in the general population: Results of a European multinational survey
11. Insomnia in primary care patients
12. An epidemiological study of insomnia among the Japanese general population
13. Quality of life in people with insomnia
14. New epidemiologic findings about insomnia and its treatment
15. Cognitive deficits in insomnia patients
16. Clinical correlates of insomnia in patients with chronic illness
17. Insomnia and heart disease: A review of epidemiologic studies
18. Incidence and remission of insomnia among elderly adults: An epidemiologic study of 6,800 persons over three years
19. Effect of sleep quality on symptoms of irritable bowel syndrome
20. Sleep in psychiatric disorders
21. Sleep and psychiatric disorders: A meta-analysis
22. Comparison of MMPI profiles in medically and psychologically based insomnias
23. Sleep disturbance and psychiatric disorders: A longitudinal epidemiological study of young adults
24. Epidemiological survey of insomniac subjects in a sample of 1,761 outpatients
25. Clinical diagnoses in 216 insomnia patients using the International Classification of Sleep Disorders (ICSD), DSM-IV and ICD-10 categories: A report from the APA/NIMH DSM-IV Field Trial
26. Polysomnographic findings in recently drug-free and clinically remitted depressed patients
27. Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy
28. Sleep research in affective illness: State of the art circa 1987
29. Electroencephalographic sleep profiles before and after cognitive behavior therapy of depression
30. Polysomnographic characteristics of young manic patients: Comparison with unipolar depressed patients and normal control subjects
31. Sleep during mania in manic-depressive males
32. Does sleep disturbance predict depression in elderly people? A study in inner London
33. Insomnia in young men and subsequent depression. The Johns Hopkins Precursors Study
34. Affective symptoms associated with the onset of major depression in the community: Findings from the US National Institute of Mental Health Epidemiologic Catchment Area Program
35. Sleep EEG recordings in generalized anxiety disorder with significant depression
36. EEG sleep in outpatients with generalized anxiety: A preliminary comparison with depressed outpatients
37. Sleep panic attacks: New clinical findings and theoretical implications
38. Sleep in patients with spontaneous panic attacks
39. Electroencephalographic sleep in panic disorder
40. Sleep disturbance as the hallmark of posttraumatic stress disorder
41. Sleep in a community sample of elderly war veterans with and without posttraumatic stress disorder
42. The sleep of patients with obsessive-compulsive disorder
43. Childhood obsessive-compulsive disorder
44. Sleep EEG of patients with obsessive-compulsive disorder
45. Electroencephalographic sleep in schizophrenia: A critical review
46. Rapid eye movement sleep eye movements in schizophrenia and depression
47. Polysomnographic characteristics of schizophrenia in comparison with mania and depression
48. Abnormal rapid eye movement latencies in schizophrenia
49. Electroencephalographic sleep in young never-medicated schizophrenics
50. Decreased slow-wave sleep and enlarged lateral ventricles in schizophrenia
51. Sleep in eating disorders
52. Sleep polygraphic variables in anorexia nervosa and depression: A comparative study in adolescents
53. Sleep architecture in anorexia nervosa and bulimia
54. Sleep-related eating in bulimia nervosa-an underreported parasomnia disorder
55. Sleep-related eating disorders: Polysomnographic correlates of a heterogeneous syndrome distinct from daytime eating disorders
56. Clinical and polysomnographic features of sleep-related eating disorder
57. Nocturnal eating syndrome in adults
58. Insomnia, self-medication, and relapse to alcoholism
59. Effects of drugs on sleep
60. Increased pressure for rapid eye movement sleep at time of hospital admission predicts relapse in nondepressed patients with primary alcoholism at 3-month follow-up
61. Sleepwalking, confusional arousals, and sleep terrors in the child
62. NREM arousal parasomnias
63. The evaluation and treatment of sleep disturbances in young children
64. Sleep and behavior problems in school-aged children
65. Sleep problems in healthy preadolescents
66. Sleep habits and sleep disturbance in elementary school-aged children
67. Sleep and psychological characteristics of children on a psychiatric inpatient unit
68. Sleep disorders in the elderly
69. Assessment and treatment of sleep disturbances in older adults
70. Insomnia in the elderly: A review for the primary care practitioner
71. Sleep in normal aging and dementia
72. Sleep in Alzheimer's disease and the sundown syndrome
73. REM latency in Alzheimer's disease
74. Sleep, EEG and mental function changes in senile dementia of the Alzheimer's type
75. Sleep disturbances in patients with mild-stage Alzheimer's disease
76. Insomnia in the elderly: Its prevalence and correlates in the general population
77. Effects of drugs on sleep
78. Fluoxetine and restless legs syndrome
79. Fluoxetine-induced sleep disturbance in depressed patients
80. Prominent eye movements during NREM sleep and REM sleep behavior disorder associated with fluoxetine treatment of depression and obsessive-compulsive disorder
81. Drug effects on REM sleep and on endogenous depression
82. Central monoamine oxidase inhibition and REM sleep
83. Total prolonged drug-induced REM sleep suppression in anxious-depressed patients
84. The effects of nefazodone on sleep architecture in depression
85. Lithium carbonate and sleep in affective disorders: Further considerations
86. Effects of selected phenothiazines on REM sleep in schizophrenics
87. Effect of prolonged chlorpromazine administration on the sleep of chronic schizophrenics
88. Lithium carbonate and sleep in affective illness
89. Behavioral treatments for insomnia
90. Treatment of chronic insomnia by restriction of time in bed
91. Meta-analysis of benzodiazepine use in the treatment of insomnia
92. Lack of residual sedation following middle-of-the-night zaleplon administration in sleep maintenance insomnia
93. Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance
94. Eating disorders
95. Nortriptyline and EEG sleep in depressed patients
96. Sleep laboratory evaluation of the effects and efficacy of trazodone in depressed insomniac patients
97. Clinical and polysomnographic effects of trazodone CR in chronic insomnia associated with dysthymia
98. Trazodone for antidepressant-associated insomnia
99. Sedative effects of antihistamines
100. Melatonin: Nature's soporific?
101. The effects of exogenous melatonin on the total sleep time and daytime alertness of chronic insomniacs: A preliminary study
102. Improvement of sleep quality in elderly people by controlled-release melatonin
103. Melatonin replacement therapy of elderly insomniacs
104. Improvement of sleep quality by melatonin
105. Melatonin in regulation of sleep and circadian rhythms
106. Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder
107. Assessing the residual effects of hypnotics
108. Health-related quality of life in patients with insomnia treated with zopiclone